Myelofibrosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Automated text replacement (-Category:Primary care +))
 
(37 intermediate revisions by 9 users not shown)
Line 4: Line 4:
{{DiseaseDisorder infobox |
{{DiseaseDisorder infobox |
   Name          = Myelofibrosis |
   Name          = Myelofibrosis |
  ICD10          = {{ICD10|C|94|5|c|81}}, {{ICD10|D|47|1|d|37}} |
  ICD9          = {{ICD9|289.89}} |
   Image          = Myelofibrosis micro.jpg|
   Image          = Myelofibrosis micro.jpg|
   Caption        = Bone marrow: Myelofibrosis: High mag HandE excellent example of myelofibrosis. <br> <small> [http://www.peir.net Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology] </small> |
   Caption        = Bone marrow: Myelofibrosis: High mag HandE excellent example of myelofibrosis. <br> <small> [http://www.peir.net Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology] </small> |
  ICDO          = 9932, 9961 |
  OMIM          = |
  DiseasesDB    = 8616 |
  MedlinePlus    = |
  MeshID          = D009191 |
}}
}}
{{Myelofibrosis}}
{{Myelofibrosis}}
{{CMG}}
{{CMG}} {{AE}} {{Sab}}; {{MJK}}; {{SR}}


{{SK}} Agnogenic myeloid metaplasia; Assmann's Disease; chronic idiopathic myelofibrosis; Heuck-Assmann disease; idiopathic myelofibrosis; primary myelofibrosis
{{SK}} Agnogenic myeloid metaplasia; AMM; Myeloid metaplasia; Myeloid metaplasia, NOS; Myelofibrosis with myeloid metaplasia; MMM; Assmann's disease; Chronic granulocytic-megakaryocytic myelosis; Chronic granulocytic megakaryocytic myelosis; Megakaryocytic myelosclerosis; Chronic idiopathic myelofibrosis; CIMF; Heuck-Assmann disease; Idiopathic myelofibrosis; Primary myelofibrosis; PMF; Prefibrotic primary myelofibrosis; Secondary myelofibrosis; Myelosclerosis; Osteomyelofibrosis; Osteomyelosclerosis; Myeloproliferative disorder
 
==[[Myelofibrosis overview|Overview]]==


==[[Myelofibrosis historical perspective|Historical Perspective]]==
==[[Myelofibrosis historical perspective|Historical Perspective]]==
Line 33: Line 28:
==[[Myelofibrosis risk factors|Risk Factors]]==
==[[Myelofibrosis risk factors|Risk Factors]]==


==[[Myelofibrosis natural history|Natural History, Complications and Prognosis]]==
==[[Myelofibrosis screening|Screening]]==
 
==[[Myelofibrosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==


==Diagnosis==
==Diagnosis==
[[Myelofibrosis staging|Staging]] | [[Myelofibrosis history and symptoms|History and Symptoms]] | [[Myelofibrosis physical examination|Physical Examination]] | [[Myelofibrosis laboratory tests|Laboratory Findings]] | [[Myelofibrosis x ray|X Ray]] | [[Myelofibrosis CT|CT]] | [[Myelofibrosis MRI|MRI]] | [[Myelofibrosis other imaging findings|Other Imaging Findings]] | [[Myelofibrosis other diagnostic studies|Other Diagnostic Studies]]
[[Myelofibrosis diagnostic study of choice|Diagnostic Study of Choice]] | [[Myelofibrosis history and symptoms|History and Symptoms]] | [[Myelofibrosis physical examination|Physical Examination]] | [[Myelofibrosis laboratory tests|Laboratory Findings]] | [[Myelofibrosis electrocardiogram|Electrocardiogram]] | [[Myelofibrosis x ray|X Ray]] | [[Myelofibrosis CT|CT]] | [[Myelofibrosis MRI|MRI]] | [[Myelofibrosis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Myelofibrosis other imaging findings|Other Imaging Findings]] | [[Myelofibrosis other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
[[Myelofibrosis medical therapy|Medical Therapy]] | [[Myelofibrosis surgery|Surgery]] | [[Myelofibrosis primary prevention|Primary Prevention]] | [[Myelofibrosis secondary prevention|Secondary Prevention]] | [[Myelofibrosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Myelofibrosis future or investigational therapies|Future or Investigational Therapies]]
[[Myelofibrosis medical therapy|Medical Therapy]] | [[Myelofibrosis surgery|Surgery]] | [[Myelofibrosis primary prevention|Primary Prevention]] | [[Myelofibrosis secondary prevention|Secondary Prevention]] | [[Myelofibrosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Myelofibrosis future or investigational therapies|Future or Investigational Therapies]]
==Case Studies==
==Case Studies==
[[Myelofibrosis case study one|Case # 1]]
[[Myelofibrosis case study one|Case # 1]]
Line 47: Line 45:
* [[Myelophthisic anemia]]
* [[Myelophthisic anemia]]


<br>
[[Category:Medicine]]
{{Hematology}}
{{Hematological malignancy histology}}
 
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Oncology]]
[[Category:Oncology]]
 
[[Category:Neurology]]
[[bn:মজ্জাকাঠিন্য]]
[[Category:Neurosurgery]]
[[de:Osteomyelofibrose]]
[[Category:Up-To-Date]]
[[fr:Splénomégalie myéloïde]]
[[it:Mielofibrosi]]
[[pl:Mielofibroza]]
 
{{WH}}
{{WS}}

Latest revision as of 06:34, 28 July 2020

For patient information, click here

Template:DiseaseDisorder infobox

Myelofibrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myelofibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myelofibrosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myelofibrosis

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myelofibrosis

CDC on Myelofibrosis

Myelofibrosis in the news

Blogs on Myelofibrosis

Directions to Hospitals Treating Myelofibrosis

Risk calculators and risk factors for Myelofibrosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]; Mohamad Alkateb, MBBCh [3]; Sujit Routray, M.D. [4]

Synonyms and keywords: Agnogenic myeloid metaplasia; AMM; Myeloid metaplasia; Myeloid metaplasia, NOS; Myelofibrosis with myeloid metaplasia; MMM; Assmann's disease; Chronic granulocytic-megakaryocytic myelosis; Chronic granulocytic megakaryocytic myelosis; Megakaryocytic myelosclerosis; Chronic idiopathic myelofibrosis; CIMF; Heuck-Assmann disease; Idiopathic myelofibrosis; Primary myelofibrosis; PMF; Prefibrotic primary myelofibrosis; Secondary myelofibrosis; Myelosclerosis; Osteomyelofibrosis; Osteomyelosclerosis; Myeloproliferative disorder

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myelofibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case # 1


Related chapters